美国嵌合体胚胎移植实践:一项调查
该研究向美国405家辅助生殖技术诊所发放14题在线问卷,调查胚胎植入前非整倍体遗传学检测使用、嵌合体判定阈值及移植意愿。252家(62.2%)完成问卷,结果显示各诊所对嵌合体胚胎移植实践和嵌合体分类存在不确定性与变异性,作者认为这为建立嵌合体阈值和标准化指南提供了机会。
要点
- 252家诊所完成问卷,其中157家私立(62.3%)、55家学术(21.8%)、40家混合(15.9%)。
- 91家(36.1%)在报告上收到嵌合体数据,其中39家(42.9%)曾移植、57家(62.6%)愿意移植嵌合体胚胎。
- 近40%诊所不确定其嵌合体移植阈值,四分之一诊所报告没有阈值。
核心结论
- 美国辅助生殖技术诊所对嵌合体胚胎的移植实践和嵌合体分类存在不确定性与变异性。
- 作者认为这些发现为建立嵌合体阈值和制定移植嵌合体胚胎的标准化指南提供了机会。
研究设计与样本
- 研究为对美国405家辅助生殖技术诊所发放14题在线问卷调查。
- 共252家(62.2%)完成问卷,包括157家私立(62.3%)、55家学术(21.8%)和40家混合(15.9%)诊所。
- 采用描述性统计和逻辑回归分析问卷回答,并识别与报告曾移植嵌合体胚胎相关的临床因素。
主要发现
- 168家(66.7%)报告对不足50%的所有体外受精周期进行胚胎植入前非整倍体遗传学检测。
- 最常用的胚胎植入前非整倍体遗传学检测技术为下一代测序,占88.9%。
- 91家(36.1%)在胚胎植入前非整倍体遗传学检测报告上收到嵌合体数据;诊所主要遗传实验室判定胚胎非整倍体和整倍体的最常见阈值分别为正常细胞<20%(36.3%)和正常细胞>80%(46.2%)。
- 91家中39家(42.9%)曾移植嵌合体胚胎,57家(62.6%)愿意移植嵌合体胚胎。
- 私立诊所(比值比1.0,95%置信区间0.5-1.8)和混合诊所(比值比0.9,95%置信区间0.4-2.1)报告曾移植嵌合体胚胎的可能性与学术诊所相当;美国东北部诊所报告曾移植嵌合体胚胎的可能性高于其他地区诊所(比值比1.5,95%置信区间0.9-2.7)。
关键数值与推荐
- 近40%诊所不确定其嵌合体移植阈值,四分之一诊所报告没有阈值。
- 多数诊所(72.6%)报告没有针对嵌合体胚胎移植的专门知情同意。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The growing use of preimplantation genetic testing with in vitro fertilization has provided clinicians with more information about the genetics of embryos. Embryos, however, sometimes result with a mixed composition of both aneuploid and euploid cells, called mosaic embryos. The interpretation of these results has varied, leading some clinicians to transfer mosaic embryos and some opt not to. In addition, laboratories providing preimplantation genetic testing for aneuploidy have differing thresholds for determining an embryo aneuploid, mosaic, or euploid. Overall practice patterns for mosaic embryo transfer practices in the United States are unknown. OBJECTIVE(S): The objectives of the study were to characterize national mosaic embryo transfer practices, including the use of preimplantation genetic testing for aneuploidy, prior history of transferring mosaic embryos, thresholds for determining mosaicism, and willingness to transfer mosaic embryos among assisted reproductive technology clinics in the United States. STUDY DESIGN: A 14 question online survey assessing current use of preimplantation genetic testing for aneuploidy, thresholds for determining mosaicism, and clinic experience and willingness to transfer mosaic embryos was e-mailed to 405 assisted reproductive technology clinics across the United States. Descriptive statistics and logistic regression were used to analyze survey responses and identify clinical factors associated with reporting having ever transferred a mosaic embryo. RESULTS: Of the 405 US assisted reproductive technology clinics contacted, 252 (62.2%) completed a survey, including 157 private (62.3%), 55 academic (21.8%), and 40 hybrid (15.9%) clinics. Most clinics (168, 66.7%) reported conducting preimplantation genetic testing for aneuploidy on less than 50% of all in vitro fertilization cycles. The most common type of preimplantation genetic testing for aneuploidy technology used was next-generation sequencing at 88.9%. Ninety-one clinics (36.1%) receive mosaicism data on their preimplantation genetic testing for aneuploidy report; the most common thresholds for determining embryo aneuploidy and euploidy by clinics' primary genetics laboratories were <20% normal (36.3%) and >80% normal (46.2%), respectively. Thirty-nine (42.9%) of the 91 have transferred and 57 (62.6%) would transfer a mosaic embryo. Nearly 40% of clinics were unsure about their thresholds for mosaic transfer and one fourth of clinics reported they had no threshold. Private (odds ratio, 1.0, 95% confidence interval, 0.5-1.8) and hybrid (odds ratio, 0.9, 95% confidence interval, 0.4-2.1) clinics were just as likely as academic clinics to report having transferred a mosaic embryo. Clinics in the northeastern United States were more likely to have transferred a mosaic embryo than clinics in other regions (odds ratio, 1.5, 95% confidence interval, 0.9-2.7). Most clinics (72.6%) report they do not have a unique consent for transfer of mosaic embryos. CONCLUSION: There is uncertainty and variability in the transfer practices of mosaic embryos and classification of mosaicism among US assisted reproductive technology clinics. These findings provide an opportunity to establish mosaicism thresholds and create standardized guidelines for transferring mosaic embryos.
引用
- Kim TG, Neblett MF, Shandley LM, et al. National mosaic embryo transfer practices: a survey. Am J Obstet Gynecol. 2018. PMID: 30278174. doi:10.1016/j.ajog.2018.09.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。